• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    AstraZeneca Pharma India Limited — Updates, 17-03-2026: General Updates

    17-03-2026 | 03:07 pm

    AstraZeneca Pharma India gained approval for Imfinzi (Durvalumab) to treat unresectable liver cancer in India. This broadens the drug's market reach, potentially increasing sales and revenue for the company.

    No comments yet. Be the first to comment!

    All announcements from AstraZeneca Pharma India Limited